| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscular Atrophy | 28 | 2019 | 333 | 4.430 |
Why?
|
| Muscle, Skeletal | 54 | 2023 | 4946 | 3.520 |
Why?
|
| Muscle Proteins | 28 | 2019 | 1154 | 2.210 |
Why?
|
| Growth Differentiation Factors | 5 | 2019 | 99 | 2.180 |
Why?
|
| Ubiquitin-Protein Ligases | 20 | 2019 | 1893 | 1.690 |
Why?
|
| Sarcopenia | 6 | 2023 | 372 | 1.640 |
Why?
|
| Bone Morphogenetic Proteins | 5 | 2019 | 841 | 1.600 |
Why?
|
| Myoblasts | 10 | 2019 | 231 | 1.510 |
Why?
|
| Muscle Fibers, Skeletal | 13 | 2018 | 542 | 1.470 |
Why?
|
| Cachexia | 9 | 2018 | 202 | 1.440 |
Why?
|
| Hypertrophy | 13 | 2019 | 559 | 1.410 |
Why?
|
| Activins | 6 | 2021 | 210 | 1.320 |
Why?
|
| Signal Transduction | 53 | 2021 | 23441 | 1.280 |
Why?
|
| Insulin-Like Growth Factor I | 17 | 2018 | 1931 | 1.140 |
Why?
|
| Muscle Development | 6 | 2017 | 259 | 1.080 |
Why?
|
| HMGA2 Protein | 3 | 2015 | 102 | 0.940 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 11 | 2014 | 175 | 0.880 |
Why?
|
| Receptors, Cholinergic | 10 | 2016 | 244 | 0.870 |
Why?
|
| Myoblasts, Skeletal | 3 | 2013 | 75 | 0.850 |
Why?
|
| Activin Receptors, Type II | 5 | 2019 | 123 | 0.850 |
Why?
|
| Neuromuscular Junction | 9 | 2016 | 405 | 0.830 |
Why?
|
| Follistatin-Related Proteins | 2 | 2021 | 48 | 0.820 |
Why?
|
| RNA-Binding Proteins | 4 | 2015 | 1897 | 0.780 |
Why?
|
| Diaphragm | 1 | 2023 | 351 | 0.770 |
Why?
|
| Agrin | 15 | 2002 | 75 | 0.740 |
Why?
|
| Myostatin | 7 | 2019 | 129 | 0.720 |
Why?
|
| Longevity | 4 | 2021 | 1065 | 0.690 |
Why?
|
| Hypogravity | 1 | 2019 | 3 | 0.680 |
Why?
|
| Aging | 11 | 2021 | 8705 | 0.680 |
Why?
|
| MyoD Protein | 3 | 2017 | 142 | 0.680 |
Why?
|
| Epidemics | 1 | 2024 | 511 | 0.620 |
Why?
|
| Manuscripts as Topic | 1 | 2017 | 15 | 0.600 |
Why?
|
| Glucuronidase | 1 | 2019 | 202 | 0.600 |
Why?
|
| Antibodies, Blocking | 3 | 2017 | 243 | 0.600 |
Why?
|
| TOR Serine-Threonine Kinases | 9 | 2018 | 2057 | 0.600 |
Why?
|
| Proto-Oncogene Proteins c-akt | 13 | 2022 | 2455 | 0.590 |
Why?
|
| Animals | 104 | 2024 | 168441 | 0.590 |
Why?
|
| Laboratory Personnel | 1 | 2016 | 19 | 0.560 |
Why?
|
| Science | 2 | 2010 | 239 | 0.540 |
Why?
|
| Space Flight | 1 | 2019 | 215 | 0.540 |
Why?
|
| Regeneration | 5 | 2017 | 1511 | 0.530 |
Why?
|
| Growth Differentiation Factor 15 | 1 | 2018 | 198 | 0.530 |
Why?
|
| Protein Kinases | 5 | 2009 | 1607 | 0.530 |
Why?
|
| Mice | 72 | 2024 | 81509 | 0.520 |
Why?
|
| Heart | 8 | 2019 | 4405 | 0.520 |
Why?
|
| Cell Line | 25 | 2021 | 15605 | 0.510 |
Why?
|
| Fibroblast Growth Factors | 3 | 2019 | 867 | 0.510 |
Why?
|
| Myosin Heavy Chains | 3 | 2019 | 405 | 0.490 |
Why?
|
| Phosphatidylinositol 3-Kinases | 9 | 2010 | 2863 | 0.480 |
Why?
|
| Satellite Cells, Skeletal Muscle | 5 | 2017 | 126 | 0.470 |
Why?
|
| Escherichia coli Proteins | 4 | 2021 | 1067 | 0.450 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 14 | 1999 | 1624 | 0.430 |
Why?
|
| Ubiquitination | 4 | 2015 | 1006 | 0.430 |
Why?
|
| Musculoskeletal System | 1 | 2015 | 188 | 0.420 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 2 | 2012 | 103 | 0.420 |
Why?
|
| Osteogenesis | 1 | 2019 | 1273 | 0.410 |
Why?
|
| Cell Differentiation | 17 | 2019 | 11526 | 0.410 |
Why?
|
| Apolipoproteins E | 3 | 2019 | 1443 | 0.410 |
Why?
|
| Rhabdomyosarcoma, Embryonal | 1 | 2013 | 100 | 0.400 |
Why?
|
| Research Personnel | 1 | 2016 | 588 | 0.390 |
Why?
|
| Eukaryotic Initiation Factor-4G | 1 | 2012 | 67 | 0.390 |
Why?
|
| Dystrophin-Associated Proteins | 2 | 2016 | 59 | 0.390 |
Why?
|
| Cardiomegaly | 6 | 2014 | 591 | 0.380 |
Why?
|
| Rats | 27 | 2023 | 23742 | 0.380 |
Why?
|
| DNA Polymerase III | 2 | 2021 | 51 | 0.370 |
Why?
|
| Biological Phenomena | 1 | 2010 | 28 | 0.360 |
Why?
|
| Mice, Knockout | 24 | 2019 | 14409 | 0.350 |
Why?
|
| Publishing | 1 | 2017 | 833 | 0.350 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2014 | 793 | 0.350 |
Why?
|
| Microfilament Proteins | 1 | 2015 | 1134 | 0.350 |
Why?
|
| Organ Size | 7 | 2019 | 2254 | 0.350 |
Why?
|
| Proto-Oncogene Proteins | 9 | 2004 | 4510 | 0.350 |
Why?
|
| Philosophy | 1 | 2010 | 68 | 0.350 |
Why?
|
| DNA Replication | 4 | 2021 | 1418 | 0.350 |
Why?
|
| Bone and Bones | 2 | 2019 | 2568 | 0.340 |
Why?
|
| F-Box Proteins | 1 | 2011 | 201 | 0.340 |
Why?
|
| Mice, Inbred C57BL | 20 | 2024 | 22163 | 0.340 |
Why?
|
| GTP Phosphohydrolases | 1 | 2013 | 517 | 0.340 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2011 | 557 | 0.330 |
Why?
|
| Up-Regulation | 8 | 2018 | 4124 | 0.330 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2023 | 8179 | 0.330 |
Why?
|
| Muscular Diseases | 2 | 2011 | 553 | 0.320 |
Why?
|
| Muscular Dystrophies | 2 | 2011 | 390 | 0.320 |
Why?
|
| Dexamethasone | 5 | 2012 | 1947 | 0.310 |
Why?
|
| RNA Interference | 7 | 2019 | 2831 | 0.310 |
Why?
|
| Cell Size | 2 | 2017 | 624 | 0.310 |
Why?
|
| Orchiectomy | 1 | 2010 | 463 | 0.310 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2015 | 2898 | 0.310 |
Why?
|
| Gene Expression | 10 | 2019 | 7584 | 0.300 |
Why?
|
| Zebrafish | 1 | 2019 | 3007 | 0.300 |
Why?
|
| Histone Deacetylases | 3 | 2019 | 719 | 0.290 |
Why?
|
| Receptors, Adrenergic, beta-2 | 3 | 2019 | 215 | 0.290 |
Why?
|
| Nerve Growth Factors | 11 | 1996 | 563 | 0.290 |
Why?
|
| Down-Regulation | 4 | 2019 | 2918 | 0.290 |
Why?
|
| DNA, Bacterial | 3 | 2021 | 1479 | 0.280 |
Why?
|
| Phosphorylation | 21 | 2024 | 8320 | 0.280 |
Why?
|
| BRCA1 Protein | 2 | 2023 | 1155 | 0.280 |
Why?
|
| ATP Citrate (pro-S)-Lyase | 2 | 2017 | 22 | 0.280 |
Why?
|
| Gene Expression Regulation | 13 | 2019 | 11902 | 0.270 |
Why?
|
| Kidney | 2 | 2019 | 7049 | 0.260 |
Why?
|
| Running | 1 | 2010 | 488 | 0.260 |
Why?
|
| Myocardium | 6 | 2019 | 4725 | 0.260 |
Why?
|
| Obesity | 3 | 2024 | 12938 | 0.260 |
Why?
|
| Research Design | 4 | 2017 | 6178 | 0.250 |
Why?
|
| Smad3 Protein | 4 | 2014 | 166 | 0.240 |
Why?
|
| Dystrophin | 2 | 2005 | 283 | 0.240 |
Why?
|
| Muscle Denervation | 3 | 2019 | 60 | 0.240 |
Why?
|
| Ubiquitin | 5 | 2022 | 839 | 0.230 |
Why?
|
| Proteome | 2 | 2022 | 1862 | 0.230 |
Why?
|
| Escherichia coli | 3 | 2021 | 4218 | 0.230 |
Why?
|
| Terfenadine | 1 | 2003 | 14 | 0.230 |
Why?
|
| Interphase | 1 | 2024 | 228 | 0.230 |
Why?
|
| Loratadine | 1 | 2003 | 12 | 0.230 |
Why?
|
| Receptors, Nerve Growth Factor | 8 | 1999 | 198 | 0.220 |
Why?
|
| Cells, Cultured | 18 | 2021 | 18964 | 0.220 |
Why?
|
| Antibodies, Monoclonal | 4 | 2017 | 9179 | 0.220 |
Why?
|
| Smad2 Protein | 3 | 2014 | 145 | 0.220 |
Why?
|
| Protein Binding | 13 | 2024 | 9352 | 0.220 |
Why?
|
| Biomedical Research | 2 | 2020 | 3429 | 0.210 |
Why?
|
| Histamine H1 Antagonists | 1 | 2003 | 100 | 0.210 |
Why?
|
| Atrophy | 5 | 2013 | 1633 | 0.210 |
Why?
|
| Rhinitis, Allergic, Seasonal | 1 | 2003 | 105 | 0.210 |
Why?
|
| Enzyme Activation | 8 | 2018 | 3597 | 0.210 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2005 | 412 | 0.210 |
Why?
|
| Hindlimb Suspension | 2 | 2019 | 75 | 0.210 |
Why?
|
| Drug Monitoring | 1 | 2008 | 962 | 0.200 |
Why?
|
| Proteasome Endopeptidase Complex | 3 | 2022 | 1320 | 0.200 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 2001 | 489 | 0.200 |
Why?
|
| Protein Phosphatase 2 | 1 | 2024 | 231 | 0.200 |
Why?
|
| Gene Expression Profiling | 4 | 2019 | 9418 | 0.200 |
Why?
|
| RNA, Small Interfering | 4 | 2019 | 3428 | 0.200 |
Why?
|
| Amino Acid Motifs | 1 | 2024 | 931 | 0.190 |
Why?
|
| Humans | 79 | 2024 | 761423 | 0.190 |
Why?
|
| Peptide Synthases | 1 | 2001 | 80 | 0.190 |
Why?
|
| Mitochondria | 3 | 2017 | 3623 | 0.190 |
Why?
|
| tau Proteins | 1 | 2011 | 2095 | 0.180 |
Why?
|
| Nuclear Proteins | 1 | 2015 | 5794 | 0.180 |
Why?
|
| Myocytes, Cardiac | 6 | 2019 | 1668 | 0.180 |
Why?
|
| Immunity | 2 | 2018 | 997 | 0.180 |
Why?
|
| Muscle Strength | 2 | 2017 | 624 | 0.180 |
Why?
|
| Motor Activity | 1 | 2010 | 2711 | 0.180 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2004 | 1171 | 0.180 |
Why?
|
| Cell Proliferation | 6 | 2024 | 10441 | 0.180 |
Why?
|
| Genes, BRCA2 | 1 | 2023 | 601 | 0.180 |
Why?
|
| Receptors, Nicotinic | 3 | 1999 | 495 | 0.170 |
Why?
|
| History, 20th Century | 3 | 2016 | 2769 | 0.170 |
Why?
|
| Neoplasms | 7 | 2019 | 22164 | 0.170 |
Why?
|
| HSC70 Heat-Shock Proteins | 1 | 2019 | 49 | 0.170 |
Why?
|
| HEK293 Cells | 6 | 2024 | 4278 | 0.170 |
Why?
|
| Testosterone | 1 | 2010 | 2472 | 0.170 |
Why?
|
| History, 16th Century | 2 | 2010 | 70 | 0.170 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2012 | 4575 | 0.170 |
Why?
|
| History, 17th Century | 2 | 2010 | 108 | 0.160 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 20093 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 1999 | 205 | 0.160 |
Why?
|
| Azacitidine | 1 | 2021 | 336 | 0.160 |
Why?
|
| Bulbo-Spinal Atrophy, X-Linked | 1 | 2018 | 4 | 0.160 |
Why?
|
| Double-Blind Method | 6 | 2022 | 12330 | 0.160 |
Why?
|
| Male | 38 | 2023 | 360736 | 0.160 |
Why?
|
| History, 18th Century | 2 | 2010 | 207 | 0.160 |
Why?
|
| Erythromycin | 1 | 1999 | 115 | 0.160 |
Why?
|
| Biotechnology | 2 | 1991 | 282 | 0.160 |
Why?
|
| Microarray Analysis | 2 | 2012 | 749 | 0.160 |
Why?
|
| Liver | 4 | 2024 | 7532 | 0.160 |
Why?
|
| South Africa | 1 | 2024 | 1841 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2015 | 988 | 0.160 |
Why?
|
| Alzheimer Disease | 5 | 2019 | 8596 | 0.150 |
Why?
|
| Blotting, Western | 3 | 2012 | 5036 | 0.150 |
Why?
|
| Cricetinae | 2 | 2021 | 2425 | 0.150 |
Why?
|
| Neoplasms, Experimental | 1 | 2023 | 1230 | 0.150 |
Why?
|
| Protein-Tyrosine Kinases | 6 | 1995 | 2423 | 0.150 |
Why?
|
| Muscular Dystrophy, Facioscapulohumeral | 1 | 2018 | 48 | 0.150 |
Why?
|
| Benzothiazoles | 1 | 2019 | 247 | 0.150 |
Why?
|
| DNA Repair | 3 | 2023 | 2045 | 0.150 |
Why?
|
| Membrane Proteins | 3 | 2013 | 7856 | 0.150 |
Why?
|
| Forkhead Transcription Factors | 4 | 2012 | 1613 | 0.150 |
Why?
|
| History, 21st Century | 2 | 2016 | 1567 | 0.150 |
Why?
|
| HIV Infections | 1 | 2024 | 17347 | 0.150 |
Why?
|
| Glycogen Synthase Kinase 3 | 3 | 2005 | 411 | 0.150 |
Why?
|
| Adult Stem Cells | 1 | 2019 | 221 | 0.140 |
Why?
|
| Isotretinoin | 1 | 1999 | 134 | 0.140 |
Why?
|
| Gene Regulatory Networks | 2 | 2019 | 1743 | 0.140 |
Why?
|
| Metallothionein | 1 | 2017 | 61 | 0.140 |
Why?
|
| Dietary Fats | 1 | 2005 | 1994 | 0.140 |
Why?
|
| Transcription Factors | 7 | 2014 | 12125 | 0.140 |
Why?
|
| Prediabetic State | 1 | 2022 | 549 | 0.140 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2017 | 191 | 0.140 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2020 | 563 | 0.130 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 802 | 0.130 |
Why?
|
| Research Report | 1 | 2019 | 367 | 0.130 |
Why?
|
| Calcineurin | 4 | 2014 | 229 | 0.130 |
Why?
|
| alpha Catenin | 1 | 2016 | 37 | 0.130 |
Why?
|
| Regenerative Medicine | 1 | 2019 | 306 | 0.130 |
Why?
|
| GRB2 Adaptor Protein | 1 | 2016 | 101 | 0.130 |
Why?
|
| DNA Helicases | 1 | 2021 | 851 | 0.130 |
Why?
|
| DNA-Binding Proteins | 3 | 2020 | 9606 | 0.130 |
Why?
|
| Mutation | 10 | 2023 | 30045 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 9 | 1998 | 4414 | 0.130 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2018 | 484 | 0.130 |
Why?
|
| Cell Separation | 1 | 2021 | 1721 | 0.130 |
Why?
|
| Transfection | 9 | 2011 | 5775 | 0.130 |
Why?
|
| Blood Proteins | 1 | 2021 | 1180 | 0.130 |
Why?
|
| Adenosine Triphosphatases | 1 | 2020 | 834 | 0.130 |
Why?
|
| Calcium | 1 | 2008 | 5727 | 0.130 |
Why?
|
| Autophagy | 3 | 2019 | 1326 | 0.120 |
Why?
|
| Citric Acid | 1 | 2015 | 123 | 0.120 |
Why?
|
| Wasting Syndrome | 2 | 2017 | 98 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 1999 | 1246 | 0.120 |
Why?
|
| NF-kappa B | 3 | 2011 | 2488 | 0.120 |
Why?
|
| Animals, Genetically Modified | 1 | 2019 | 1561 | 0.120 |
Why?
|
| Peer Review, Research | 1 | 2017 | 340 | 0.120 |
Why?
|
| DNA Damage | 2 | 2021 | 2446 | 0.120 |
Why?
|
| Glucocorticoids | 4 | 2017 | 2161 | 0.120 |
Why?
|
| Safety | 1 | 2019 | 1150 | 0.120 |
Why?
|
| Mitochondria, Muscle | 1 | 2015 | 172 | 0.110 |
Why?
|
| GTP-Binding Protein alpha Subunit, Gi2 | 1 | 2013 | 34 | 0.110 |
Why?
|
| PPAR alpha | 1 | 2015 | 175 | 0.110 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2015 | 200 | 0.110 |
Why?
|
| Phenotype | 9 | 2014 | 16606 | 0.110 |
Why?
|
| Creatine Kinase | 2 | 2009 | 686 | 0.110 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2020 | 1133 | 0.110 |
Why?
|
| Acne Vulgaris | 1 | 1999 | 358 | 0.110 |
Why?
|
| Body Weight | 5 | 2017 | 4618 | 0.110 |
Why?
|
| Myositis, Inclusion Body | 1 | 2014 | 145 | 0.110 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2006 | 687 | 0.110 |
Why?
|
| Enzyme Inhibitors | 4 | 2018 | 3712 | 0.110 |
Why?
|
| Agriculture | 2 | 1991 | 191 | 0.100 |
Why?
|
| Quinolines | 1 | 2018 | 764 | 0.100 |
Why?
|
| Postmortem Changes | 1 | 2012 | 119 | 0.100 |
Why?
|
| Homeostasis | 2 | 2019 | 3321 | 0.100 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 1793 | 0.100 |
Why?
|
| Sp1 Transcription Factor | 1 | 2012 | 140 | 0.100 |
Why?
|
| Energy Metabolism | 3 | 2012 | 2881 | 0.100 |
Why?
|
| Imidazoles | 1 | 2018 | 1180 | 0.100 |
Why?
|
| Mice, SCID | 3 | 2017 | 2626 | 0.100 |
Why?
|
| Disease Models, Animal | 7 | 2024 | 18247 | 0.100 |
Why?
|
| Cell Nucleus | 2 | 2015 | 2908 | 0.100 |
Why?
|
| Trans-Activators | 1 | 2001 | 2856 | 0.100 |
Why?
|
| GTP-Binding Protein alpha Subunits, G12-G13 | 1 | 2011 | 43 | 0.100 |
Why?
|
| Receptors, Growth Factor | 3 | 1999 | 326 | 0.100 |
Why?
|
| Mice, Transgenic | 10 | 2014 | 9535 | 0.100 |
Why?
|
| Starvation | 1 | 2012 | 142 | 0.100 |
Why?
|
| Cardiovascular System | 1 | 2019 | 835 | 0.100 |
Why?
|
| Templates, Genetic | 1 | 2011 | 189 | 0.090 |
Why?
|
| Cell Enlargement | 1 | 2011 | 60 | 0.090 |
Why?
|
| Lipolysis | 1 | 2012 | 212 | 0.090 |
Why?
|
| Myogenin | 2 | 2001 | 55 | 0.090 |
Why?
|
| Stem Cell Transplantation | 1 | 2019 | 1600 | 0.090 |
Why?
|
| Physical Conditioning, Animal | 1 | 2014 | 365 | 0.090 |
Why?
|
| Patient Satisfaction | 1 | 2003 | 3460 | 0.090 |
Why?
|
| Automation, Laboratory | 1 | 2011 | 102 | 0.090 |
Why?
|
| Immunologic Factors | 2 | 2022 | 1588 | 0.090 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2014 | 258 | 0.090 |
Why?
|
| Protein Isoforms | 3 | 2019 | 1699 | 0.090 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2010 | 141 | 0.090 |
Why?
|
| Abelson murine leukemia virus | 1 | 1990 | 41 | 0.090 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2012 | 379 | 0.090 |
Why?
|
| Gene Deletion | 4 | 2005 | 2667 | 0.090 |
Why?
|
| Genetic Engineering | 2 | 1998 | 933 | 0.090 |
Why?
|
| Drug Administration Schedule | 1 | 2018 | 4852 | 0.090 |
Why?
|
| Neuropeptides | 1 | 2016 | 944 | 0.090 |
Why?
|
| Tumor Necrosis Factors | 1 | 2010 | 107 | 0.090 |
Why?
|
| Female | 26 | 2023 | 392581 | 0.090 |
Why?
|
| Ubiquitins | 1 | 2011 | 366 | 0.090 |
Why?
|
| Communicable Diseases | 1 | 2018 | 875 | 0.090 |
Why?
|
| Trypanosoma brucei brucei | 2 | 1986 | 45 | 0.080 |
Why?
|
| Leukemia Virus, Murine | 1 | 1990 | 94 | 0.080 |
Why?
|
| Sympathetic Nervous System | 1 | 2012 | 518 | 0.080 |
Why?
|
| Receptor Aggregation | 3 | 1997 | 72 | 0.080 |
Why?
|
| Adipogenesis | 1 | 2012 | 368 | 0.080 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2015 | 435 | 0.080 |
Why?
|
| Denervation | 3 | 2009 | 265 | 0.080 |
Why?
|
| Placebos | 2 | 2014 | 1667 | 0.080 |
Why?
|
| Dioxoles | 1 | 2009 | 95 | 0.080 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2014 | 5665 | 0.080 |
Why?
|
| Homeodomain Proteins | 1 | 2018 | 2416 | 0.080 |
Why?
|
| Myofibrils | 1 | 2009 | 141 | 0.080 |
Why?
|
| Oxygen Consumption | 1 | 2015 | 1863 | 0.080 |
Why?
|
| Activin Receptors, Type I | 1 | 2009 | 134 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2018 | 10766 | 0.080 |
Why?
|
| Severity of Illness Index | 3 | 2021 | 15838 | 0.080 |
Why?
|
| Sirolimus | 2 | 2014 | 1533 | 0.080 |
Why?
|
| Complement System Proteins | 4 | 2022 | 788 | 0.080 |
Why?
|
| Survival Rate | 2 | 2021 | 12720 | 0.080 |
Why?
|
| Cell Survival | 5 | 2013 | 5790 | 0.080 |
Why?
|
| Membrane Glycoproteins | 5 | 1998 | 3702 | 0.080 |
Why?
|
| Transcription, Genetic | 7 | 2017 | 7595 | 0.080 |
Why?
|
| Follistatin | 1 | 2009 | 137 | 0.080 |
Why?
|
| Heart Diseases | 3 | 2011 | 2785 | 0.080 |
Why?
|
| Arginine | 1 | 2012 | 933 | 0.080 |
Why?
|
| Proteins | 3 | 2012 | 6032 | 0.080 |
Why?
|
| Osteocalcin | 1 | 2008 | 274 | 0.080 |
Why?
|
| Physical Endurance | 1 | 2010 | 366 | 0.080 |
Why?
|
| Serine | 1 | 2012 | 830 | 0.070 |
Why?
|
| Leupeptins | 1 | 2007 | 113 | 0.070 |
Why?
|
| 3T3 Cells | 9 | 1996 | 1085 | 0.070 |
Why?
|
| Proteomics | 3 | 2021 | 3845 | 0.070 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 789 | 0.070 |
Why?
|
| Oncogene Proteins | 2 | 2006 | 718 | 0.070 |
Why?
|
| Body Composition | 2 | 2022 | 2422 | 0.070 |
Why?
|
| Thermogenesis | 1 | 2012 | 475 | 0.070 |
Why?
|
| History, 19th Century | 1 | 2010 | 720 | 0.070 |
Why?
|
| Data Interpretation, Statistical | 1 | 2017 | 2691 | 0.070 |
Why?
|
| Phosphorus | 1 | 2008 | 336 | 0.070 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2010 | 584 | 0.070 |
Why?
|
| Histones | 1 | 2017 | 2580 | 0.070 |
Why?
|
| Genes | 3 | 1986 | 1844 | 0.070 |
Why?
|
| DNA, Mitochondrial | 1 | 2012 | 865 | 0.070 |
Why?
|
| Carrier Proteins | 4 | 2009 | 4936 | 0.070 |
Why?
|
| Brain-Derived Neurotrophic Factor | 7 | 1996 | 602 | 0.070 |
Why?
|
| Models, Biological | 6 | 2012 | 9469 | 0.070 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2007 | 174 | 0.070 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2014 | 1250 | 0.070 |
Why?
|
| Gene Dosage | 1 | 2011 | 1218 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 5 | 2007 | 3734 | 0.070 |
Why?
|
| Aged | 16 | 2022 | 169235 | 0.070 |
Why?
|
| Electric Impedance | 1 | 2011 | 756 | 0.070 |
Why?
|
| Neurotrophin 3 | 7 | 1995 | 61 | 0.070 |
Why?
|
| Plasmids | 4 | 2020 | 2269 | 0.070 |
Why?
|
| Bacterial Proteins | 1 | 2020 | 3846 | 0.070 |
Why?
|
| Adipose Tissue, Brown | 1 | 2012 | 764 | 0.070 |
Why?
|
| Artificial Intelligence | 1 | 2020 | 2578 | 0.070 |
Why?
|
| Fibrosis | 2 | 2024 | 2048 | 0.070 |
Why?
|
| Chemotactic Factors | 1 | 2006 | 197 | 0.070 |
Why?
|
| Protein Biosynthesis | 2 | 2012 | 2114 | 0.070 |
Why?
|
| Acetylation | 2 | 2019 | 1055 | 0.060 |
Why?
|
| Myosins | 1 | 2007 | 405 | 0.060 |
Why?
|
| Hepatocytes | 2 | 2024 | 1232 | 0.060 |
Why?
|
| Inflammation | 3 | 2024 | 10762 | 0.060 |
Why?
|
| Oncogenes | 2 | 1993 | 1222 | 0.060 |
Why?
|
| Cloning, Molecular | 3 | 2001 | 4174 | 0.060 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2007 | 727 | 0.060 |
Why?
|
| Ribosomal Protein S6 Kinases | 2 | 2001 | 203 | 0.060 |
Why?
|
| Occupational Health | 1 | 1991 | 806 | 0.060 |
Why?
|
| Genes, Reporter | 2 | 2007 | 1529 | 0.060 |
Why?
|
| Amino Acid Sequence | 10 | 2002 | 13449 | 0.060 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2018 | 2243 | 0.060 |
Why?
|
| Glucose | 2 | 2007 | 4347 | 0.060 |
Why?
|
| Histamine H1 Antagonists, Non-Sedating | 1 | 2003 | 16 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 5 | 2013 | 3792 | 0.060 |
Why?
|
| Eating | 1 | 2010 | 1538 | 0.060 |
Why?
|
| Complement C2 | 3 | 1981 | 70 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 2 | 2020 | 7409 | 0.060 |
Why?
|
| Receptors, Cell Surface | 4 | 1996 | 2821 | 0.050 |
Why?
|
| Benzamides | 1 | 2009 | 1370 | 0.050 |
Why?
|
| Insulin | 3 | 2007 | 6602 | 0.050 |
Why?
|
| Creatinine | 1 | 2008 | 1899 | 0.050 |
Why?
|
| Blood Chemical Analysis | 1 | 2005 | 437 | 0.050 |
Why?
|
| Motor Endplate | 2 | 2019 | 20 | 0.050 |
Why?
|
| Heat-Shock Proteins | 1 | 1986 | 796 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2006 | 570 | 0.050 |
Why?
|
| Adult | 13 | 2022 | 221148 | 0.050 |
Why?
|
| Tissue Distribution | 2 | 2005 | 2265 | 0.050 |
Why?
|
| Aged, 80 and over | 9 | 2021 | 58956 | 0.050 |
Why?
|
| Amino Acids | 1 | 2008 | 1718 | 0.050 |
Why?
|
| Linear Models | 1 | 2012 | 5869 | 0.050 |
Why?
|
| Exons | 2 | 2005 | 2393 | 0.050 |
Why?
|
| Synaptic Membranes | 2 | 1999 | 89 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2010 | 1960 | 0.050 |
Why?
|
| Molecular Sequence Data | 10 | 2002 | 17644 | 0.050 |
Why?
|
| Creatine Kinase, MM Form | 1 | 2001 | 10 | 0.050 |
Why?
|
| Autoantigens | 1 | 2006 | 892 | 0.050 |
Why?
|
| Glycogen Synthase Kinases | 1 | 2001 | 40 | 0.050 |
Why?
|
| Hydrocortisone | 1 | 2010 | 1815 | 0.050 |
Why?
|
| Oligopeptides | 1 | 2007 | 1187 | 0.050 |
Why?
|
| Myogenic Regulatory Factor 5 | 1 | 2001 | 26 | 0.050 |
Why?
|
| Parathyroid Hormone | 1 | 2008 | 1803 | 0.050 |
Why?
|
| Constriction, Pathologic | 2 | 2019 | 1097 | 0.050 |
Why?
|
| Receptor, Ciliary Neurotrophic Factor | 4 | 1996 | 36 | 0.050 |
Why?
|
| Immunohistochemistry | 3 | 2012 | 11073 | 0.050 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 12688 | 0.050 |
Why?
|
| Hospitalization | 1 | 2021 | 10718 | 0.050 |
Why?
|
| Drug Discovery | 2 | 2020 | 1051 | 0.050 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2001 | 85 | 0.050 |
Why?
|
| Ligases | 1 | 2003 | 332 | 0.050 |
Why?
|
| RNA | 2 | 2010 | 2723 | 0.050 |
Why?
|
| Middle Aged | 13 | 2022 | 220826 | 0.050 |
Why?
|
| Immunoblotting | 1 | 2004 | 1647 | 0.050 |
Why?
|
| Escherichia coli K12 | 1 | 2021 | 34 | 0.050 |
Why?
|
| Iritis | 1 | 1980 | 15 | 0.050 |
Why?
|
| NFATC Transcription Factors | 2 | 2014 | 389 | 0.050 |
Why?
|
| Complement Activation | 1 | 2022 | 452 | 0.050 |
Why?
|
| HLA Antigens | 4 | 1981 | 1371 | 0.050 |
Why?
|
| RNA, Messenger | 5 | 2004 | 12796 | 0.050 |
Why?
|
| Immobilization | 1 | 2001 | 229 | 0.050 |
Why?
|
| Stem Cells | 1 | 2013 | 3522 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2008 | 4016 | 0.040 |
Why?
|
| Vitamins | 1 | 2008 | 1634 | 0.040 |
Why?
|
| Heart Transplantation | 1 | 2014 | 3234 | 0.040 |
Why?
|
| Treatment Outcome | 4 | 2018 | 64651 | 0.040 |
Why?
|
| Muscles | 2 | 2022 | 1576 | 0.040 |
Why?
|
| Tamoxifen | 1 | 2004 | 965 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1990 | 2824 | 0.040 |
Why?
|
| Replication Origin | 1 | 2020 | 77 | 0.040 |
Why?
|
| Laminin | 2 | 2000 | 408 | 0.040 |
Why?
|
| Neurons | 6 | 2002 | 9462 | 0.040 |
Why?
|
| Antibodies, Antinuclear | 2 | 1980 | 344 | 0.040 |
Why?
|
| Ligands | 4 | 2019 | 3271 | 0.040 |
Why?
|
| Isoenzymes | 2 | 2001 | 1688 | 0.040 |
Why?
|
| Time Factors | 4 | 2007 | 39975 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 1999 | 360 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2021 | 2469 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2016 | 1974 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 12143 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2004 | 1970 | 0.040 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2019 | 128 | 0.040 |
Why?
|
| Fibroblasts | 6 | 2002 | 4140 | 0.040 |
Why?
|
| Patient Compliance | 1 | 2008 | 2690 | 0.040 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2019 | 111 | 0.040 |
Why?
|
| Cardiotoxins | 1 | 2017 | 36 | 0.040 |
Why?
|
| Receptors, Mitogen | 1 | 1997 | 61 | 0.040 |
Why?
|
| Ciprofloxacin | 1 | 2020 | 312 | 0.040 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2019 | 305 | 0.040 |
Why?
|
| Gels | 1 | 1999 | 422 | 0.040 |
Why?
|
| Genotype | 3 | 2021 | 13009 | 0.040 |
Why?
|
| Cyclins | 1 | 1999 | 594 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 1 | 2004 | 2645 | 0.040 |
Why?
|
| Tyrosine | 3 | 1997 | 1440 | 0.040 |
Why?
|
| Biomimetics | 1 | 2018 | 171 | 0.040 |
Why?
|
| Heart Failure | 2 | 2019 | 11674 | 0.040 |
Why?
|
| New York City | 1 | 2019 | 731 | 0.040 |
Why?
|
| Genomic Instability | 1 | 2021 | 709 | 0.040 |
Why?
|
| Cricetulus | 1 | 2019 | 814 | 0.040 |
Why?
|
| Fluorescence | 1 | 2019 | 756 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2022 | 15498 | 0.030 |
Why?
|
| Recombinant Proteins | 3 | 2017 | 6532 | 0.030 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2018 | 345 | 0.030 |
Why?
|
| Systole | 1 | 2019 | 937 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2021 | 1870 | 0.030 |
Why?
|
| Administration, Cutaneous | 1 | 1999 | 713 | 0.030 |
Why?
|
| Flavonoids | 1 | 1999 | 445 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 16979 | 0.030 |
Why?
|
| Anabolic Agents | 1 | 2019 | 256 | 0.030 |
Why?
|
| CHO Cells | 1 | 2019 | 1388 | 0.030 |
Why?
|
| Transgenes | 1 | 1999 | 1010 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 3779 | 0.030 |
Why?
|
| Vaccination | 3 | 2018 | 3381 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2011 | 8999 | 0.030 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2011 | 3204 | 0.030 |
Why?
|
| Antibodies, Viral | 3 | 2018 | 3155 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2020 | 803 | 0.030 |
Why?
|
| DNA | 4 | 2023 | 7219 | 0.030 |
Why?
|
| Pressure | 1 | 2019 | 1155 | 0.030 |
Why?
|
| Bone Density | 1 | 2008 | 3551 | 0.030 |
Why?
|
| Hepatocyte Growth Factor | 1 | 1997 | 270 | 0.030 |
Why?
|
| Protein S | 1 | 1995 | 30 | 0.030 |
Why?
|
| Kinetics | 3 | 2019 | 6374 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2020 | 1494 | 0.030 |
Why?
|
| Cardiolipins | 1 | 2015 | 81 | 0.030 |
Why?
|
| Nutrition Surveys | 1 | 2022 | 1728 | 0.030 |
Why?
|
| Blotting, Northern | 3 | 1995 | 1545 | 0.030 |
Why?
|
| Vitamin D | 1 | 2008 | 3301 | 0.030 |
Why?
|
| Type C Phospholipases | 1 | 1995 | 287 | 0.030 |
Why?
|
| Genome, Bacterial | 1 | 2020 | 783 | 0.030 |
Why?
|
| Receptors, Neuropeptide | 1 | 1995 | 106 | 0.030 |
Why?
|
| Collagen Type III | 1 | 2014 | 91 | 0.030 |
Why?
|
| Cell Cycle Proteins | 2 | 2007 | 3447 | 0.030 |
Why?
|
| Rhodamine 123 | 2 | 1993 | 37 | 0.030 |
Why?
|
| Microcirculation | 1 | 1999 | 1273 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 2018 | 1463 | 0.030 |
Why?
|
| Transplantation, Heterotopic | 1 | 2014 | 174 | 0.030 |
Why?
|
| Survival of Motor Neuron 1 Protein | 1 | 2014 | 64 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2017 | 1847 | 0.030 |
Why?
|
| Rhodamines | 2 | 1993 | 178 | 0.030 |
Why?
|
| Thigh | 1 | 2014 | 241 | 0.030 |
Why?
|
| Extracellular Matrix Proteins | 1 | 1997 | 829 | 0.030 |
Why?
|
| Smad Proteins | 1 | 2014 | 156 | 0.030 |
Why?
|
| Cell Division | 4 | 1995 | 4466 | 0.030 |
Why?
|
| COS Cells | 3 | 2002 | 1130 | 0.030 |
Why?
|
| Adenosine Triphosphate | 2 | 2015 | 1989 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2021 | 3969 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2008 | 39117 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2017 | 1990 | 0.030 |
Why?
|
| E2F1 Transcription Factor | 1 | 2013 | 178 | 0.030 |
Why?
|
| PC12 Cells | 4 | 1993 | 317 | 0.030 |
Why?
|
| Zinc | 1 | 2017 | 690 | 0.030 |
Why?
|
| Drug Combinations | 1 | 1999 | 2048 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2004 | 3312 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2001 | 2448 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 1999 | 1486 | 0.030 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 1088 | 0.030 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2020 | 1048 | 0.030 |
Why?
|
| Macaca mulatta | 1 | 2019 | 2332 | 0.030 |
Why?
|
| International Cooperation | 1 | 2018 | 1422 | 0.020 |
Why?
|
| Neuromuscular Diseases | 1 | 2014 | 258 | 0.020 |
Why?
|
| Motor Neurons | 1 | 1997 | 870 | 0.020 |
Why?
|
| Risk Factors | 2 | 2016 | 74167 | 0.020 |
Why?
|
| Animals, Newborn | 2 | 2013 | 2677 | 0.020 |
Why?
|
| Adipocytes, Brown | 1 | 2012 | 150 | 0.020 |
Why?
|
| Influenza Vaccines | 2 | 2014 | 767 | 0.020 |
Why?
|
| Peripheral Nerves | 1 | 1995 | 479 | 0.020 |
Why?
|
| Alkaloids | 1 | 1992 | 192 | 0.020 |
Why?
|
| Macrophages | 2 | 2021 | 5768 | 0.020 |
Why?
|
| Heart-Assist Devices | 2 | 2014 | 1287 | 0.020 |
Why?
|
| United States Environmental Protection Agency | 1 | 1991 | 139 | 0.020 |
Why?
|
| Carbazoles | 1 | 1992 | 220 | 0.020 |
Why?
|
| Government Agencies | 1 | 1991 | 160 | 0.020 |
Why?
|
| Cohort Studies | 3 | 2019 | 41446 | 0.020 |
Why?
|
| Receptor, trkB | 1 | 1991 | 124 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2012 | 4354 | 0.020 |
Why?
|
| I-kappa B Proteins | 1 | 2011 | 211 | 0.020 |
Why?
|
| Synapses | 2 | 1997 | 1769 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2017 | 1509 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2012 | 695 | 0.020 |
Why?
|
| Sarcomeres | 1 | 2013 | 368 | 0.020 |
Why?
|
| Influenza, Human | 2 | 2018 | 1521 | 0.020 |
Why?
|
| Protective Agents | 1 | 2011 | 150 | 0.020 |
Why?
|
| Binding Sites | 4 | 2002 | 6055 | 0.020 |
Why?
|
| Protein Transport | 1 | 2016 | 1966 | 0.020 |
Why?
|
| Growth Substances | 1 | 1992 | 768 | 0.020 |
Why?
|
| Norepinephrine | 1 | 2012 | 897 | 0.020 |
Why?
|
| Base Sequence | 5 | 1995 | 12450 | 0.020 |
Why?
|
| Synaptic Transmission | 1 | 2016 | 1173 | 0.020 |
Why?
|
| Collagen | 1 | 1997 | 2638 | 0.020 |
Why?
|
| Myosin Light Chains | 1 | 2009 | 121 | 0.020 |
Why?
|
| Synthetic Biology | 1 | 2011 | 185 | 0.020 |
Why?
|
| Ventricular Myosins | 1 | 2009 | 65 | 0.020 |
Why?
|
| Life Style | 1 | 2020 | 3914 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 1999 | 2727 | 0.020 |
Why?
|
| Seasons | 1 | 2014 | 1519 | 0.020 |
Why?
|
| Actomyosin | 1 | 2009 | 109 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2021 | 3541 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 1999 | 6309 | 0.020 |
Why?
|
| Structure-Activity Relationship | 3 | 2002 | 3076 | 0.020 |
Why?
|
| Environmental Health | 1 | 1991 | 289 | 0.020 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 1997 | 1841 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1986 | 1306 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 1993 | 1093 | 0.020 |
Why?
|
| Capillaries | 2 | 2002 | 755 | 0.020 |
Why?
|
| Dystroglycans | 2 | 1998 | 62 | 0.020 |
Why?
|
| Receptor, trkC | 2 | 1999 | 63 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 1995 | 1651 | 0.020 |
Why?
|
| Polyubiquitin | 1 | 2007 | 68 | 0.020 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 1978 | 2163 | 0.020 |
Why?
|
| Liver Glycogen | 1 | 2007 | 35 | 0.020 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2007 | 123 | 0.020 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2007 | 72 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 2011 | 1202 | 0.020 |
Why?
|
| Oncogene Protein v-akt | 1 | 2007 | 129 | 0.020 |
Why?
|
| Arthritis, Rheumatoid | 2 | 1986 | 3755 | 0.020 |
Why?
|
| Exercise Test | 1 | 2014 | 2129 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 2019 | 3816 | 0.020 |
Why?
|
| Peptide Fragments | 2 | 2013 | 5115 | 0.020 |
Why?
|
| Ventricular Remodeling | 1 | 2014 | 1266 | 0.020 |
Why?
|
| Adolescent | 2 | 2008 | 88313 | 0.020 |
Why?
|
| Vasoconstriction | 1 | 2009 | 592 | 0.020 |
Why?
|
| Integrins | 2 | 2002 | 834 | 0.020 |
Why?
|
| Phosphotyrosine | 2 | 1999 | 456 | 0.020 |
Why?
|
| Prevalence | 1 | 2022 | 15717 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1986 | 1058 | 0.020 |
Why?
|
| Extracellular Fluid | 1 | 2006 | 165 | 0.020 |
Why?
|
| Thymus Gland | 1 | 1990 | 1243 | 0.020 |
Why?
|
| Skin | 1 | 1999 | 4481 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2011 | 1742 | 0.010 |
Why?
|
| Young Adult | 2 | 2022 | 59207 | 0.010 |
Why?
|
| Salicylates | 1 | 2004 | 127 | 0.010 |
Why?
|
| Synovial Fluid | 1 | 1986 | 393 | 0.010 |
Why?
|
| Receptor, trkA | 2 | 1996 | 159 | 0.010 |
Why?
|
| Environmental Monitoring | 1 | 1990 | 1458 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2007 | 2561 | 0.010 |
Why?
|
| Child | 3 | 2008 | 80162 | 0.010 |
Why?
|
| Haploidy | 2 | 1981 | 133 | 0.010 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2006 | 663 | 0.010 |
Why?
|
| I-kappa B Kinase | 1 | 2004 | 250 | 0.010 |
Why?
|
| Brain Chemistry | 2 | 2000 | 959 | 0.010 |
Why?
|
| Lysine | 1 | 2007 | 992 | 0.010 |
Why?
|
| Fasting | 1 | 2009 | 1602 | 0.010 |
Why?
|
| Mutagenesis | 2 | 1999 | 1232 | 0.010 |
Why?
|
| Hindlimb | 1 | 2004 | 513 | 0.010 |
Why?
|
| Antibodies, Neutralizing | 1 | 2012 | 1943 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2012 | 3207 | 0.010 |
Why?
|
| Weight Loss | 1 | 2014 | 2683 | 0.010 |
Why?
|
| Antigens, Surface | 1 | 1986 | 1609 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2014 | 4370 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 2 | 1998 | 1342 | 0.010 |
Why?
|
| Basement Membrane | 1 | 2002 | 349 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 1990 | 1903 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 2007 | 1674 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2013 | 5789 | 0.010 |
Why?
|
| Actins | 1 | 2009 | 2050 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2006 | 2065 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2014 | 10089 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2014 | 4575 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 1990 | 2549 | 0.010 |
Why?
|
| T-Lymphocytes | 2 | 1990 | 10194 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 2004 | 2016 | 0.010 |
Why?
|
| Chick Embryo | 1 | 2002 | 982 | 0.010 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2009 | 1723 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 2 | 1997 | 6132 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1995 | 2748 | 0.010 |
Why?
|
| Biological Transport | 2 | 1995 | 2092 | 0.010 |
Why?
|
| Prothrombin | 1 | 2000 | 191 | 0.010 |
Why?
|
| Torpedo | 1 | 1999 | 170 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2018 | 36423 | 0.010 |
Why?
|
| Cell Fusion | 1 | 1999 | 294 | 0.010 |
Why?
|
| Cyclosporine | 1 | 2001 | 778 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 1999 | 436 | 0.010 |
Why?
|
| Glycoproteins | 1 | 1986 | 2208 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 1999 | 574 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 1999 | 750 | 0.010 |
Why?
|
| Quail | 1 | 1997 | 40 | 0.010 |
Why?
|
| Solubility | 1 | 1999 | 1091 | 0.010 |
Why?
|
| Properdin | 1 | 1976 | 29 | 0.010 |
Why?
|
| Monocytes | 1 | 2006 | 2572 | 0.010 |
Why?
|
| Ciliary Neurotrophic Factor | 1 | 1997 | 77 | 0.010 |
Why?
|
| Paralysis | 1 | 1998 | 250 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1999 | 1762 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2014 | 12951 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2002 | 3087 | 0.010 |
Why?
|
| Genes, Lethal | 1 | 1996 | 225 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 1986 | 5490 | 0.010 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 1995 | 48 | 0.010 |
Why?
|
| Histocompatibility Antigens | 1 | 1976 | 467 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2011 | 3812 | 0.010 |
Why?
|
| Echocardiography | 1 | 2007 | 4991 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2019 | 54415 | 0.010 |
Why?
|
| Rhabdomyosarcoma | 1 | 1997 | 358 | 0.010 |
Why?
|
| Schwann Cells | 1 | 1995 | 197 | 0.010 |
Why?
|
| Autoradiography | 1 | 1995 | 730 | 0.010 |
Why?
|
| Chromatography, Affinity | 1 | 1995 | 532 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 1997 | 1750 | 0.010 |
Why?
|
| Fungal Proteins | 1 | 1997 | 910 | 0.010 |
Why?
|
| Isotope Labeling | 1 | 1995 | 393 | 0.010 |
Why?
|
| Muscle Contraction | 1 | 1998 | 1201 | 0.010 |
Why?
|
| Lumbosacral Region | 1 | 1995 | 293 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1996 | 1992 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2002 | 3687 | 0.010 |
Why?
|
| Mutagenesis, Insertional | 1 | 1995 | 656 | 0.010 |
Why?
|
| Drug Synergism | 1 | 1997 | 1755 | 0.010 |
Why?
|
| Indole Alkaloids | 1 | 1992 | 23 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2000 | 3810 | 0.010 |
Why?
|
| United States | 2 | 1991 | 72339 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1996 | 2179 | 0.010 |
Why?
|
| Heterozygote | 1 | 1999 | 2803 | 0.010 |
Why?
|
| Brain | 1 | 1999 | 27107 | 0.010 |
Why?
|
| Ganglia, Spinal | 1 | 1995 | 526 | 0.010 |
Why?
|
| Prefrontal Cortex | 1 | 2002 | 2218 | 0.010 |
Why?
|
| Reference Values | 1 | 1999 | 4921 | 0.010 |
Why?
|
| Staurosporine | 1 | 1992 | 242 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 1995 | 1791 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 1995 | 1033 | 0.010 |
Why?
|
| Protein Engineering | 1 | 1995 | 549 | 0.010 |
Why?
|
| DNA Primers | 1 | 1995 | 2820 | 0.010 |
Why?
|
| Genetic Variation | 1 | 1986 | 6581 | 0.010 |
Why?
|
| Models, Neurological | 1 | 1998 | 1767 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1991 | 1141 | 0.010 |
Why?
|
| Cytokines | 1 | 2004 | 7392 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1993 | 1900 | 0.010 |
Why?
|
| Pheochromocytoma | 1 | 1991 | 328 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1993 | 2498 | 0.000 |
Why?
|
| Cross-Linking Reagents | 1 | 1991 | 686 | 0.000 |
Why?
|
| Macromolecular Substances | 1 | 1990 | 1435 | 0.000 |
Why?
|
| Drug Resistance | 1 | 1993 | 1595 | 0.000 |
Why?
|
| Hippocampus | 1 | 2000 | 3763 | 0.000 |
Why?
|
| Astrocytes | 1 | 1995 | 1345 | 0.000 |
Why?
|
| Phytohemagglutinins | 1 | 1986 | 168 | 0.000 |
Why?
|
| Variant Surface Glycoproteins, Trypanosoma | 1 | 1986 | 8 | 0.000 |
Why?
|
| Immunosorbent Techniques | 1 | 1986 | 176 | 0.000 |
Why?
|
| Amyloid beta-Peptides | 1 | 2000 | 3837 | 0.000 |
Why?
|
| DNA Restriction Enzymes | 1 | 1986 | 551 | 0.000 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1991 | 732 | 0.000 |
Why?
|
| Disease Progression | 1 | 2002 | 13502 | 0.000 |
Why?
|
| Organ Specificity | 1 | 1990 | 1967 | 0.000 |
Why?
|
| Receptors, Interleukin-2 | 1 | 1986 | 562 | 0.000 |
Why?
|
| Models, Molecular | 1 | 1995 | 5439 | 0.000 |
Why?
|
| Karyotyping | 1 | 1986 | 1171 | 0.000 |
Why?
|
| Molecular Weight | 1 | 1986 | 2188 | 0.000 |
Why?
|
| Fetal Blood | 1 | 1990 | 1347 | 0.000 |
Why?
|
| Chromosomes | 1 | 1986 | 577 | 0.000 |
Why?
|
| Receptors, Immunologic | 1 | 1986 | 1412 | 0.000 |
Why?
|
| Rheumatoid Factor | 1 | 1978 | 185 | 0.000 |
Why?
|
| Remission, Spontaneous | 1 | 1978 | 384 | 0.000 |
Why?
|
| Homozygote | 1 | 1981 | 1796 | 0.000 |
Why?
|
| Antibody Formation | 1 | 1978 | 1398 | 0.000 |
Why?
|
| Recombination, Genetic | 1 | 1976 | 1525 | 0.000 |
Why?
|
| Genetic Linkage | 1 | 1976 | 2382 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1990 | 26212 | 0.000 |
Why?
|
| Alleles | 1 | 1981 | 6922 | 0.000 |
Why?
|
| Autoantibodies | 1 | 1978 | 2124 | 0.000 |
Why?
|
| Pedigree | 1 | 1976 | 4589 | 0.000 |
Why?
|
| Chromosome Mapping | 1 | 1976 | 4638 | 0.000 |
Why?
|
| Infant | 1 | 1990 | 36205 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1990 | 42254 | 0.000 |
Why?
|
| Recurrence | 1 | 1978 | 8469 | 0.000 |
Why?
|